Interim Phase II Results Using Panitumumab-IRDye800CW during Transoral Robotic Surgery in Patients with Oropharyngeal Cancer.
Stone LD, Kasten BB, Rao S, Gonzalez ML, Stevens TM, Lin D, Carroll W, Greene B, Moore LS, Fuson A, James S, Hartman YE, McCammon S, Panuganti B, Nabell LM, Li Y, Li M, Bailey L, Rosenthal EL, Jeyarajan H, Thomas CM, Warram JM.
Stone LD, et al. Among authors: stevens tm.
Clin Cancer Res. 2024 Sep 13;30(18):4016-4028. doi: 10.1158/1078-0432.CCR-24-0940.
Clin Cancer Res. 2024.
PMID: 39012279
Clinical Trial.